{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:35:47Z","timestamp":1792290947022,"version":"4.4.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>\n                    Biliary tract cancers (BTCs) are aggressive malignancies with limited treatment options. Despite advances with durvalumab plus chemotherapy, prognosis remains poor. The tumor immune microenvironment (TIME) is increasingly recognized as a determinant of immunotherapy response, yet its spatial organization in BTC is poorly understood. We applied multiplex immunofluorescence to pre-treatment tumor samples from 11 patients with advanced BTC, staining for CD4, CD8, CD20, and CD163 to identify T cells, B cells, and macrophages. Across 198 regions of interest sampled at the invasive tumor margin, approximately 400,000 individual cells were segmented and phenotyped. Spatial organization was analyzed using hierarchical clustering, distance-based approaches, and cellular neighborhood classification. Unsupervised analysis identified two distinct immune phenotypes, one enriched in CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells and CD163\n                    <jats:sup>+<\/jats:sup>\n                    macrophages and the other in CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells and CD20\n                    <jats:sup>+<\/jats:sup>\n                    B cells. These phenotypes displayed distinct spatial architectures, with CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells and CD20\n                    <jats:sup>+<\/jats:sup>\n                    B cells acting as organizing hubs, respectively. Targeted sequencing, available for a subset of cases, showed a higher frequency of co-occurring TP53 and ARID1A alterations in the B-cell\u2013enriched phenotype. No statistically significant differences in overall or progression-free survival were observed between immune phenotypes. However, among patients treated with adjuvant cisplatin\/gemcitabine alone, lower CD20\/CD8 fractions and higher CD163 abundance at baseline were associated with improved survival. Spatial immune profiling revealed distinct BTC immune architectures at the invasive margin, with different possible impact on survival, thus warranting further characterization and validation in larger cohorts.\n                  <\/jats:p>","DOI":"10.3389\/pore.2026.1612389","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:10:06Z","timestamp":1779945006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers"],"prefix":"10.3389","volume":"32","author":[{"given":"Federico","family":"Rossari","sequence":"first","affiliation":[{"name":"Department of Oncology, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]},{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sala","sequence":"additional","affiliation":[{"name":"Center for Omics Sciences, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]},{"name":"University of Milan","place":["Milan, Italy"]},{"name":"Politecnico di Milano","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Rimini","sequence":"additional","affiliation":[{"name":"Department of Oncology, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]},{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Camera","sequence":"additional","affiliation":[{"name":"Department of Oncology, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Persano","sequence":"additional","affiliation":[{"name":"Department of Oncology, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tonon","sequence":"additional","affiliation":[{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]},{"name":"Center for Omics Sciences, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bonini","sequence":"additional","affiliation":[{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]},{"name":"Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Cangi","sequence":"additional","affiliation":[{"name":"Pathology Unit, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Pecciarini","sequence":"additional","affiliation":[{"name":"Pathology Unit, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Doglioni","sequence":"additional","affiliation":[{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]},{"name":"Pathology Unit, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]},{"name":"Pathology Unit, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Balestrieri","sequence":"additional","affiliation":[{"name":"Center for Omics Sciences, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]},{"name":"Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pedica","sequence":"additional","affiliation":[{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]},{"name":"Pathology Unit, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Casadei-Gardini","sequence":"additional","affiliation":[{"name":"Department of Oncology, IRCCS San Raffaele Scientific Institute","place":["Milan, Italy"]},{"name":"\u201cVita-Salute\u201d San Raffaele University","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102223","DOI":"10.1016\/j.clinre.2023.102223","article-title":"New epidemiologic trends in cholangiocarcinoma","volume":"47","author":"Pascale","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","article-title":"NCCN guidelines\u00ae insights: biliary tract cancers, version 2.2023","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"B4","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"114199","DOI":"10.1016\/j.ejca.2024.114199","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: a large real-life worldwide population","volume":"208","author":"Rimini","year":"2024","journal-title":"Eur J Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73","author":"Fabris","year":"2021","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1037945","DOI":"10.3389\/fimmu.2023.1037945","article-title":"Immune microenvironment of cholangiocarcinoma: biological concepts and treatment strategies","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/cancers12082190","article-title":"Molecular and immunological characterization of biliary tract cancers: a paradigm shift towards a personalized medicine","volume":"12","author":"Malenica","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41416-022-01933-0","article-title":"Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis","volume":"127","author":"Charbel","year":"2022","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/curroncol32010024","article-title":"The immune landscape and its potential for immunotherapy in advanced biliary tract cancer","volume":"32","author":"Santoso","year":"2024","journal-title":"Curr Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"103969","DOI":"10.1016\/j.esmoop.2024.103969","article-title":"Prognostic value of tumor-infiltrating lymphocytes in distal extrahepatic bile duct carcinoma","volume":"9","author":"Jun","year":"2024","journal-title":"ESMO Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jhep.2016.08.012","article-title":"Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages","volume":"66","author":"Raggi","year":"2017","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"72","author":"Job","year":"2020","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3390\/ijms24043086","article-title":"Multiplex immunofluorescence: a powerful tool in cancer immunotherapy","volume":"24","author":"Sheng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1288802","DOI":"10.3389\/fimmu.2023.1288802","article-title":"Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications","volume":"14","author":"Kumar","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","article-title":"The single-cell pathology landscape of breast cancer","volume":"578","author":"Jackson","year":"2020","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-030-00934-2_30","article-title":"Cell detection with star-convex polygons","author":"Schmidt","year":"2018"},{"key":"B22","unstructured":""},{"key":"B23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","article-title":"Squidpy: a scalable framework for spatial omics analysis","volume":"19","author":"Palla","year":"2022","journal-title":"Nat Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science (80)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.medj.2024.10.023","article-title":"Tertiary lymphoid structures and cancer immunotherapy: from bench to bedside","volume":"6","author":"Peyraud","year":"2025","journal-title":"Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e006433","DOI":"10.1136\/jitc-2022-006433","article-title":"Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy","volume":"11","author":"van Elsas","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"103375","DOI":"10.1016\/j.ebiom.2021.103375","article-title":"Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target","volume":"67","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117080","DOI":"10.1016\/j.biopha.2024.117080","article-title":"Tumor-infiltrating T lymphocytes: a promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma","volume":"177","author":"Hua","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.it.2024.07.003","article-title":"Mutant ARID1A: igniting cancer immunotherapy","volume":"45","author":"Vokshi","year":"2024","journal-title":"Trends Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1148389","DOI":"10.3389\/fmolb.2023.1148389","article-title":"The role of p53 in anti-tumor immunity and response to immunotherapy","volume":"10","author":"Carlsen","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-20-2404","article-title":"ARID1A mutation may define an immunologically active subgroup in patients with microsatellite stable colorectal cancer","volume":"27","author":"Mehrvarz Sarshekeh","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1016\/j.cell.2024.04.025","article-title":"ARID1A suppresses R-loop-mediated STING-Type I interferon pathway activation of anti-tumor immunity","volume":"187","author":"Maxwell","year":"2024","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","article-title":"B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy?","volume":"28","author":"Lauss","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2026.1612389\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:10:07Z","timestamp":1779945007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2026.1612389\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":37,"alternative-id":["10.3389\/pore.2026.1612389"],"URL":"https:\/\/doi.org\/10.3389\/pore.2026.1612389","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1612389"}}